NEW YORK, NY / ACCESS Newswire / November 21, 2025 / Nixxy Inc. (NASDAQ:NIXX) ("Nixxy" or the "Company"), an emerging AI data infrastructure and telecommunications company, today announced that its AI-powered sales acceleration platform, Leadnova.ai, has entered User Acceptance Testing (UAT), with a commercial beta launch targeted for Q1 2026. Leadnova.ai positions Nixxy to enter the AI data market, unlock future data monetization opportunities, and tightly align its product roadmap with the Company's AI data infrastructure strategy and robust telecom delivery network.

image for news Nixxy Inc. Announces its AI-powered Sales Acceleration Platform, Leadnova.ai Enters User Acceptance Testing, Targeting Commercial Beta Launch in Q1 2026

AMD: Trillion-Dollar Market Cap In Sight - Upgrade To Buy — Positive

AMD   Seeking Alpha — November 21, 2025

Advanced Micro Devices, Inc. has reported great growth tailwinds across the expanding x86 market share, the improving data center monetization opportunities, and the ambitious long-term targets. These growth engines imply the potential expansion in its market capitalization to over $1T, allowing the company to eventually join the Trillion Dollar club alongside NVDA and AVGO. I am also impressed by AMD's growing bullish support at current levels, as observed in the sideways trading cadence during the market wide meltdown.

image for news AMD: Trillion-Dollar Market Cap In Sight - Upgrade To Buy

VinFast Reports Unaudited Third Quarter 2025 Financial Results — Neutral

VFS   PRNewsWire — November 21, 2025

SINGAPORE , Nov. 21, 2025 /PRNewswire/ -- VinFast Auto Ltd. ("VinFast" or the "Company") (Nasdaq: VFS), a pure-play electric vehicle ("EV") manufacturer with the mission of making EVs accessible to everyone, today announced its unaudited financial results for the third quarter ended September 30, 2025.

image for news VinFast Reports Unaudited Third Quarter 2025 Financial Results

NEW YORK--(BUSINESS WIRE)---- $LLY #GLP1--Ilant Health announced that it will offer employers direct contracting and transparent pricing of Eli Lilly and Company (Lilly) obesity management medicines. Employers working with Ilant Health will have the option of accessing obesity management medicines at a transparent and predictable price point starting in early 2026. Medications obtained through this collaboration will be fulfilled by a licensed mail-order pharmacy, supporting convenience, continuity, and a sea.

image for news Ilant Health Enhances Comprehensive Cardiometabolic Care with Direct Contracting for Obesity Management Medicine for Employers

PALO ALTO, Calif.--(BUSINESS WIRE)--A study by Forrester Consulting on behalf of Navan (NASDAQ: NAVN), the leading all-in-one business travel, payments, and expense management platform, found the Navan platform saved customers 16% annually on business travel, based on a composite organization analysis¹. Combining cost savings and productivity gains, the study found that Navan delivered a 376% return on investment (ROI) during a three-year period. The Forrester Consulting analysis illustrates ho.

image for news Navan Saved Customers 16% on Business Travel According to Total Economic Impact Study

Insperity Declares Quarterly Dividend of $0.60 — Neutral

NSP   Business Wire — November 21, 2025

HOUSTON--(BUSINESS WIRE)--Insperity, Inc. (NYSE: NSP), a leading provider of human resources and business performance solutions for America's best businesses, today announced that its board of directors has declared a quarterly cash dividend of $0.60 per share. The cash dividend will be paid on December 23, 2025, to all stockholders of record as of December 9, 2025. About Insperity Since 1986, Insperity's mission has been to help businesses succeed so communities prosper. Offering a suite of th.

image for news Insperity Declares Quarterly Dividend of $0.60

DENVER--(BUSINESS WIRE)--Royal Gold to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series on Thursday, December 4, 2025.

image for news Royal Gold to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series on Thursday, December 4, 2025

Why Sigma Lithium Rallied This Week — Positive

SGML   The Motley Fool — November 21, 2025

The Chairman of the world's second-largest lithium processor made bullish comments on lithium prices for 2026. A sell-side analyst upped his price target on Sigma Lithium's shares two days later.

image for news Why Sigma Lithium Rallied This Week

BJ's Wholesale Club (BJ) Surpasses Q3 Earnings Estimates — Positive

BJ   Zacks Investment Research — November 21, 2025

BJ's Wholesale Club (BJ) came out with quarterly earnings of $1.16 per share, beating the Zacks Consensus Estimate of $1.1 per share. This compares to earnings of $1.18 per share a year ago.

image for news BJ's Wholesale Club (BJ) Surpasses Q3 Earnings Estimates

Resist AI FOMO And Stick With Your Long-Term Plan — Neutral

CHAT  CSCO  SCHD  VNQ  XLU   Seeking Alpha — November 21, 2025

AI stocks are getting a lot of hype right now. But history shows that revolutionary technologies almost always become overvalued and overinvested, leading to eventual corrections. Disciplined, long-term investing - resisting FOMO and sticking to a well-designed plan -remains the best path to enduring wealth.

image for news Resist AI FOMO And Stick With Your Long-Term Plan

Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.

image for news Gold market analysis for November 21 - Key intra-day price entry levels for active traders

Shares of AnaptysBio fell 14% in premarket trading on Friday after the U.S. drug developer and Tesaro, a unit of Britain's GSK , filed lawsuits against each other, with both claiming a breach in a partnership deal for a cancer drug.

image for news AnaptysBio shares tumble after legal fight with GSK over cancer drug license

NVIDIA delivered a blockbuster third-quarter earnings report yesterday, surpassing Wall Street expectations with record revenue of $57 billion and providing an upbeat forecast that contrasts concerns about an AI bubble, according to CNBC. CEO Jensen Huang highlighted robust demand for the company's AI chips, stating NVIDIA has visibility into a half-trillion-dollar sales pipeline for 2025 and 2026, excluding recent major deals like expansions with Anthropic and Saudi Arabia.

image for news NVIDIA's Strong Earnings Report Dispels AI Bubble Fears Amid Circular Financing Concerns

ZIM Integrated Shipping Services Ltd. (ZIM) Q3 2025 Earnings Call Transcript — Neutral

ZIM   Seeking Alpha — November 20, 2025

ZIM Integrated Shipping Services Ltd. ( ZIM ) Q3 2025 Earnings Call November 20, 2025 8:00 AM EST Company Participants Elana Holzman - Head of Investor Relations Eliyahu Glickman - President & CEO Xavier Destriau - Executive VP & CFO Conference Call Participants Omar Nokta - Jefferies LLC, Research Division Marco Limite - Barclays Bank PLC, Research Division Alexia Dogani - JPMorgan Chase & Co, Research Division Tianyu Fu - Citigroup Inc., Research Division Presentation Operator Thank you for standing by.

image for news ZIM Integrated Shipping Services Ltd. (ZIM) Q3 2025 Earnings Call Transcript

New York, New York--(Newsfile Corp. - November 20, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) resulting from allegations that Tandem Diabetes Care may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Tandem Diabetes Care securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

image for news ROSEN, A LEADING LAW FIRM, Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM

Bath & Body Works' stock suffers historic plunge after a disappointing earnings report, with the new CEO outlining a series of missteps.

image for news Bath & Body Works stock is plunging. What went wrong for the hand-soap and candle maker?

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming January 12, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of Primo Brands Corporation (“Primo Brands” or the “Company”) (NYSE: PRMB) investors who purchased or otherwise acquired: (1) Primo Water Corporation (“Primo Water”) common stock between June 17, 2024 and November 8, 2024, inclusive; and/or (2) Primo Brands common stock between November 11, 2024 and November 6, 202.

image for news Deadline Approaching: Primo Brands Corporation (PRMB) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith

Walmart Has Built a Digital Powerhouse—With Help From WhatsApp — Neutral

WMT   Investopedia — November 20, 2025

Walmart is sliding into its Chilean shoppers' DMs—and it's working.

image for news Walmart Has Built a Digital Powerhouse—With Help From WhatsApp

New York, New York--(Newsfile Corp. - November 20, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Freeport-McMoRan Inc. (NYSE: FCX) and certain of the Company's senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities laws. If you invested in Freeport, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/freeport-mcmoran-inc-class-action-lawsuit.

image for news FCX INVESTORS: BFA Law Reminds Freeport-McMoRan Inc. Investors with Losses to Contact the Firm Before the Imminent January 12 Securities Class Action Deadline

New York, New York--(Newsfile Corp. - November 20, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Ardent Health, Inc. (NYSE: ARDT) for potential violations of the federal securities laws. If you invested in Ardent, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ardent-health-inc-class-action-investigation.

image for news ARDT INVESTORS: BFA Law Reminds Ardent Health, Inc. Investors with Losses to Contact the Firm About its Ongoing Securities Investigation